Nitroxoline treatment of Balamuthia mandrillaris triggers genomic crisis, transcriptional collapse, and incomplete encystment via copper and iron chelation
PLOS Pathogens · 05.11.2026 · 22 (11) · e1014783
DOI: 10.1371/journal.ppat.1014783 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, online erschienen am 05.11.2026. Verfasst von Kaitlin A Marquis und 4 weiteren Autor:innen. Beteiligte Einrichtung: Biohub, San Francisco, California, United States of America. Die Arbeit nennt 112 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chan Zuckerberg Biohub SF, Division of Intramural Research, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Balamuthia mandrillaris is a free-living amoeba that can infect the central nervous system to cause granulomatous amebic encephalitis (GAE), a fatal disease with mortality rates up to 90%. GAE is typically treated with a six-drug regimen with limited efficacy and significant toxicity. Our lab previously identified nitroxoline, a quinolone antibiotic, as a promising therapeutic complement to the existing regimen, and in 2021 nitroxoline was first successfully used to treat a human patient. In this study, we elucidate nitroxoline’s mechanism of action using a combination of genomics, transcriptomics, chemical complementation, growth assays, and electron microscopy. In service of this goal, an annotated draft genome of B. mandrillaris strain CDC:V039 was generated using long read sequencing, yielding over 32,000 predicted protein coding sequences, the majority of which were present on telomere-to-telomere predicted chromosomal contigs. Leveraging this resource, comparative transcriptomics were used to characterize encystment responses to three different cellular stressors: nitroxoline, galactose, and hypoxia. Our findings reveal that nitroxoline-induced cysts undergo transcriptional collapse and genomic and structural destabilization via copper and iron chelation, and that preformed cysts are also disrupted by nitroxoline. These data provide insight into nitroxoline’s multifaceted impact on B. mandrillaris growth and cellular processes and advance our understanding of the transcriptional landscape associated with stress induced encystment. Our findings support the continued clinical study of nitroxoline as a complement to the existing regimen.
Autor:innen und Institutionen
- Biohub, San Francisco, California, United States of America.
- Department of Medicine, Division of Infectious Diseases, University of California, San Francisco, California, United States of America.
- Department of Biochemistry and Biophysics, University of California, San Francisco, California, United States of America.
ORCID-Profile: Kaitlin A Marquis, Joseph L DeRisi
Förderung
- Chan Zuckerberg Biohub SF
- Division of Intramural Research, National Institute of Allergy and Infectious Diseases
Zitieren
APA
Marquis, K. A., Spottiswoode, N., Detweiler, A. M., Neff, N., & DeRisi, J. L. (2026). Nitroxoline treatment of Balamuthia mandrillaris triggers genomic crisis, transcriptional collapse, and incomplete encystment via copper and iron chelation. PLOS Pathogens, 22(11), e1014783. https://doi.org/10.1371/journal.ppat.1014783
Vancouver
Marquis KA, Spottiswoode N, Detweiler AM, Neff N, DeRisi JL. Nitroxoline treatment of Balamuthia mandrillaris triggers genomic crisis, transcriptional collapse, and incomplete encystment via copper and iron chelation. PLOS Pathogens. 2026;22(11):e1014783. doi:10.1371/journal.ppat.1014783
BibTeX
@article{Marquis2026,
author = {Marquis, Kaitlin A and Spottiswoode, Natasha and Detweiler, Angela M and Neff, Norma and DeRisi, Joseph L},
title = {Nitroxoline treatment of Balamuthia mandrillaris triggers genomic crisis, transcriptional collapse, and incomplete encystment via copper and iron chelation},
journal = {PLOS Pathogens},
year = {2026},
volume = {22},
number = {11},
pages = {e1014783},
doi = {10.1371/journal.ppat.1014783}
}
EUVIMED